These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21298814)

  • 1. Topical tacrolimus and pimecrolimus: cancer, infections.
    Prescrire Int; 2010 Nov; 19(110):257. PubMed ID: 21298814
    [No Abstract]   [Full Text] [Related]  

  • 2. An update on the safety and tolerability of pimecrolimus cream 1%: evidence from clinical trials and post-marketing surveillance.
    Langley RG; Luger TA; Cork MJ; Schneider D; Paul C
    Dermatology; 2007; 215 Suppl 1():27-44. PubMed ID: 18174691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern?
    Ormerod AD
    Br J Dermatol; 2005 Oct; 153(4):701-5. PubMed ID: 16181449
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between exposure to topical tacrolimus or pimecrolimus and cancers.
    Hui RL; Lide W; Chan J; Schottinger J; Yoshinaga M; Millares M
    Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients.
    Eichenfield LF; Thaci D; de Prost Y; Puig L; Paul C
    Dermatology; 2007; 215 Suppl 1():3-17. PubMed ID: 18174689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facial flush reaction after alcohol ingestion during topical pimecrolimus and tacrolimus treatment.
    Stinco G; Piccirillo F; Sallustio M; Patrone P
    Dermatology; 2009; 218(1):71-2. PubMed ID: 18832812
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical tacrolimus and pimecrolimus: future directions.
    Ling MR
    Semin Cutan Med Surg; 2001 Dec; 20(4):268-74. PubMed ID: 11770914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risk with topical pimecrolimus and tacrolimus.
    Prescrire Int; 2005 Dec; 14(80):223. PubMed ID: 16400745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus.
    Tatlican S; Eren C; Atacan D; Dalgic U; Canpolat F; Eskioglu F
    J Dermatolog Treat; 2010 Sep; 21(5):322-3. PubMed ID: 19832287
    [No Abstract]   [Full Text] [Related]  

  • 10. Elidel and protopic.
    Med Lett Drugs Ther; 2005 Mar; 47(1205):25. PubMed ID: 15795682
    [No Abstract]   [Full Text] [Related]  

  • 11. Molluscum contagiosum infection associated with pimecrolimus use in pityriasis alba.
    Goksugur N; Ozbostanci B; Goksugur SB
    Pediatr Dermatol; 2007; 24(5):E63-5. PubMed ID: 17958783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    van der Laan JR
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1816; author reply 1817. PubMed ID: 16121669
    [No Abstract]   [Full Text] [Related]  

  • 13. Pimecrolimus and tacrolimus: the US FDA public health advisory.
    Maddin S
    Skin Therapy Lett; 2005 May; 10(4):1-3. PubMed ID: 15986080
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical tacrolimus: cancers.
    Prescrire Int; 2012 Oct; 21(131):239. PubMed ID: 23185848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical calcineurin inhibitors revisited.
    Qureshi A; Fischer MA
    Arch Dermatol; 2007 Apr; 143(4):545-6. PubMed ID: 17438195
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema.
    Meurer M; Lubbe J; Kapp A; Schneider D
    Dermatology; 2007; 215 Suppl 1():18-26. PubMed ID: 18174690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical calcineurin inhibitors labeling: putting the "box" in perspective.
    Stern RS
    Arch Dermatol; 2006 Sep; 142(9):1233-5. PubMed ID: 16983018
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force.
    Berger TG; Duvic M; Van Voorhees AS; VanBeek MJ; Frieden IJ;
    J Am Acad Dermatol; 2006 May; 54(5):818-23. PubMed ID: 16635663
    [No Abstract]   [Full Text] [Related]  

  • 19. [Contact allergy with tacrolimus then pimecrolimus].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2008 Jan; 135(1):89. PubMed ID: 18342086
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%.
    Bellini V; Simonetti S; Lisi P
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):113-5. PubMed ID: 18181988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.